|Bid||154.50 x 100|
|Ask||155.35 x 100|
|Day's Range||154.79 - 156.13|
|52 Week Range||133.64 - 184.21|
|PE Ratio (TTM)||14.72|
|Dividend & Yield||4.60 (2.96%)|
|1y Target Est||N/A|
When it seems like everyone is panicking, these high-quality dividend stocks will help keep you calm.
Pfizer, Inc. (PFE) announced that an FDA advisory committee has recommended approval of its biosimilar version of ESA Epogen and Procrit.
In 1Q17, Amgen’s (AMGN) Nplate generated revenues of ~$154 million, which reflected a year-over-year growth rate of 9%.